Author

Adel Ahmed Rashad

Eli Lilly (United States)ORCID 0000-0001-6113-0333Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexandra N. TalaricoiD· 1 shared Alexej DickiD· 1 shared Emily M. EsqueaiD· 1 shared Jessica MerzyiD· 1 shared Joris BeldiD· 1 shared Lorela CirakuiD· 1 shared Mauricio J. ReginatoiD· 1 shared Nicole Lynn SimoneiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra N. TalaricoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 22, 2023

Discovery of novel brain permeable human ACSS2 inhibitors for blocking breast cancer brain metastatic growth

Emily M. Esquea, Lorela Ciraku, Riley G. Young…·Alexej Dick

This study identifies and validates two novel ACSS2 inhibitors that cross the blood-brain barrier and reduce breast cancer brain metastasis in vitro and ex vivo.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky